Effects of uremic serum and uremic toxins on hepatic uptake of digoxin

Therapeutic Drug Monitoring
Masayuki TsujimotoYasufumi Sawada

Abstract

Not only the renal clearance but also the hepatic clearance of drugs varies with the progression of renal failure. The aim of this study was to investigate the effects of human uremic serum and various uremic toxins on the hepatic uptake of digoxin (DX), a drug mainly excreted into bile in patients with severe renal failure, using isolated rat and human hepatocytes as model systems. Uremic serum inhibited the uptake of DX into rat hepatocytes in a concentration-dependent manner, whereas normal serum did not affect the uptake. In addition, 3-carboxy-4-methyl-5-propyl-2-furanpropanoic acid (CMPF), hippuric acid, indole-3-acetic acid, indoxyl sulfate, and p-cresol (PC) concentration dependently inhibited the uptake. CMPF and PC at the concentration of 400 microM, which is within the plasma concentration range attained in patients with renal failure, inhibited the uptake of DX into rat hepatocytes by 27% and 23%, respectively. In human hepatocytes, 10% uremic serum, 400 microM CMPF, and 400 microM PC inhibited the uptake of DX by 23.3%, 23.4%, and 28.2%, respectively. In conclusion, our results suggest that hepatic uptake of DX is likely to be inhibited by uremic toxins, such as CMPF and PC, present in the serum of patients with re...Continue Reading

References

Aug 1, 1978·Clinical Pharmacology and Therapeutics·A RaneR A Branch
Feb 1, 1985·Journal of Pharmacobio-dynamics·T MizumaS Awazu
Nov 1, 1981·Journal of Pharmacobio-dynamics·K YamaokaT Uno
Jun 1, 1997·Molecular Pharmacology·L ZhangK M Giacomini
Sep 18, 1997·Proceedings of the National Academy of Sciences of the United States of America·B NoéP J Meier
Aug 15, 1998·Biochemical and Biophysical Research Communications·F Meyer-WentrupH Koepsell
Dec 23, 1999·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·G LesafferR Vanholder
Apr 26, 2000·The Journal of Biological Chemistry·J KönigD Keppler
Aug 11, 2000·Kidney International. Supplement·A DhondtN Lameire
Oct 21, 2000·European Journal of Pharmacology·Z H HuangM Takano
May 1, 2001·Biochemical and Biophysical Research Communications·W SunM D Erion
Jun 1, 2002·Journal of the American Society of Nephrology : JASN·Francois A LeblondVincent Pichette
Jul 24, 2002·Pharmaceutical Research·Takaaki KodawaraKen-ichi Inu
Jul 31, 2002·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Riccardo Maria FagugliRaymond Vanholder
Jan 22, 2003·Seminars in Dialysis·Albert W Dreisbach, Juan J L Lertora
Jan 23, 2003·The Journal of Pharmacology and Experimental Therapeutics·Yoshihisa ShitaraYuichi Sugiyama
Mar 29, 2003·Physiological Reviews·Michael Trauner, James L Boyer
Apr 5, 2003·Kidney International·Raymond VanholderUNKNOWN European Uremic Toxin Work Group (EUTox)
Oct 9, 2003·Clinical Pharmacokinetics·Hans Lennernäs
Apr 30, 2004·Clinical Pharmacology and Therapeutics·Dennis W SchneckAli Raza
May 26, 2004·The Journal of Pharmacology and Experimental Therapeutics·Masaru HiranoYuichi Sugiyama
Aug 3, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Hong SunLeslie Z Benet
Dec 24, 2004·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Cuiping ChenTeresa A Smolarek
Jun 18, 2005·Clinical Pharmacology and Therapeutics·Mikko NiemiPertti J Neuvonen
Jul 5, 2005·The Journal of Pharmacology and Experimental Therapeutics·Lichuan LiuK Sandy Pang
Oct 4, 2005·Clinical Pharmacology and Therapeutics·Lauri I KajosaariJanne T Backman
Jun 20, 2006·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Yi-an BiDavid B Duignan
Jan 27, 2007·Biopharmaceutics & Drug Disposition·Suwako ItoYasufumi Sawada

❮ Previous
Next ❯

Citations

May 4, 2011·Journal of Pharmaceutical Sciences·Hiroshi WatanabeToru Maruyama
Feb 19, 2015·Pharmacology Research & Perspectives·Hiroshi WatanabeToru Maruyama
Oct 18, 2013·Kidney International·Catherine K YeungJonathan Himmelfarb
Jun 2, 2015·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Yuichi IchimuraHiroshi Saitoh
Jul 4, 2015·Clinical Pharmacokinetics·Frederique RodieuxMarc Pfister
Nov 30, 2012·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Masayuki TsujimotoKohshi Nishiguchi
Jan 18, 2012·Journal of Clinical Pharmacology·Judith NaudVincent Pichette
Aug 21, 2010·The Journal of Pharmacy and Pharmacology·Masayuki TsujimotoKohshi Nishiguchi
Oct 15, 2013·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Masayuki TsujimotoKohshi Nishiguchi
Apr 12, 2015·Néphrologie & thérapeutique·Judith NaudVincent Pichette
Oct 13, 2017·Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy·Piotr Jan NowakMichal Nowicki
Sep 15, 2017·Expert Review of Clinical Pharmacology·Alexander J Prokopienko, Thomas D Nolin
Jun 21, 2015·Pharmacological Reviews·Dustin R WalshPeter A Friedman
Oct 24, 2014·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Jennifer C RyanBrian S Decker
Sep 17, 2020·Toxins·Amanda L Graboski, Matthew R Redinbo
Aug 29, 2016·European Journal of Clinical Pharmacology·Willemijn L EppengaPeter A G M De Smet

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Therapeutic Apheresis and Dialysis : Official Peer-reviewed Journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy
Masayuki TsujimotoKohshi Nishiguchi
Drug Metabolism and Disposition : the Biological Fate of Chemicals
H SunL Z Benet
The Journal of Pharmacology and Experimental Therapeutics
Yasuhiro TsutsumiMasaki Otagiri
Regulatory Toxicology and Pharmacology : RTP
Donna A VolpeRobert J Parker
© 2022 Meta ULC. All rights reserved